Concepedia

Publication | Open Access

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

DOIFull Paper Access

40

Citations

25

References

2021

Year

Arturo Chang Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruíz, Consuelo Macías Abraham, Laura Rodríguez-Noda, Carmen Valenzuela‐Silva, Belinda Sánchez-Ramírez, Rocmira Pérez-Nicado, Tays Hernández-García, Ivette Orosa-Vázquez,
The Lancet Regional Health - Americas

References

YearCitations

Page 1